4
Changes in Ownership
Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-20-031809
Options or other derivatives
- Director acquired 10,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Yamada Tadataka Director | 2020-05-21 | Grant or award · Stock Option | +10,000 | 10,000 | D | ||
Loading xslF345X03/doc4.xml…